121 related articles for article (PubMed ID: 19964170)
1. Pilot study of irreversible electroporation for intracranial surgery.
Garcia PA; Rossmeisl JH; Robertson J; Ellis TL; Davalos RV
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():6513-6. PubMed ID: 19964170
[TBL] [Abstract][Full Text] [Related]
2. Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation.
Ellis TL; Garcia PA; Rossmeisl JH; Henao-Guerrero N; Robertson J; Davalos RV
J Neurosurg; 2011 Mar; 114(3):681-8. PubMed ID: 20560725
[TBL] [Abstract][Full Text] [Related]
3. Intracranial nonthermal irreversible electroporation: in vivo analysis.
Garcia PA; Rossmeisl JH; Neal RE; Ellis TL; Olson JD; Henao-Guerrero N; Robertson J; Davalos RV
J Membr Biol; 2010 Jul; 236(1):127-36. PubMed ID: 20668843
[TBL] [Abstract][Full Text] [Related]
4. The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems.
Neal RE; Davalos RV
Ann Biomed Eng; 2009 Dec; 37(12):2615-25. PubMed ID: 19757056
[TBL] [Abstract][Full Text] [Related]
5. Predictive therapeutic planning for irreversible electroporation treatment of spontaneous malignant glioma.
Garcia PA; Kos B; Rossmeisl JH; Pavliha D; Miklavčič D; Davalos RV
Med Phys; 2017 Sep; 44(9):4968-4980. PubMed ID: 28594449
[TBL] [Abstract][Full Text] [Related]
6. Non-thermal irreversible electroporation for deep intracranial disorders.
Garcia PA; Neal RE; Rossmeisl JH; Davalos RV
Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():2743-6. PubMed ID: 21095962
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study to delineate irreversible electroporation from thermal damage using the arrhenius equation.
Shafiee H; Garcia PA; Davalos RV
J Biomech Eng; 2009 Jul; 131(7):074509. PubMed ID: 19640145
[TBL] [Abstract][Full Text] [Related]
8. Electrical conductivity changes during irreversible electroporation treatment of brain cancer.
Garcia PA; Rossmeisl JH; Davalos RV
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():739-42. PubMed ID: 22254416
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
10. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.
van den Bos W; de Bruin DM; Jurhill RR; Savci-Heijink CD; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna-Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
World J Urol; 2016 May; 34(5):657-64. PubMed ID: 26296371
[TBL] [Abstract][Full Text] [Related]
11. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
[TBL] [Abstract][Full Text] [Related]
12. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
Davalos RV; Bhonsle S; Neal RE
Prostate; 2015 Jul; 75(10):1114-8. PubMed ID: 25809014
[TBL] [Abstract][Full Text] [Related]
13. A statistical model for multidimensional irreversible electroporation cell death in tissue.
Golberg A; Rubinsky B
Biomed Eng Online; 2010 Feb; 9():13. PubMed ID: 20187951
[TBL] [Abstract][Full Text] [Related]
14. In vivo irreversible electroporation kidney ablation: experimentally correlated numerical models.
Neal RE; Garcia PA; Kavnoudias H; Rosenfeldt F; Mclean CA; Earl V; Bergman J; Davalos RV; Thomson KR
IEEE Trans Biomed Eng; 2015 Feb; 62(2):561-9. PubMed ID: 25265626
[TBL] [Abstract][Full Text] [Related]
15. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation: a new ablation modality--clinical implications.
Rubinsky B; Onik G; Mikus P
Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
[TBL] [Abstract][Full Text] [Related]
17. Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas.
Rossmeisl JH; Garcia PA; Pancotto TE; Robertson JL; Henao-Guerrero N; Neal RE; Ellis TL; Davalos RV
J Neurosurg; 2015 Oct; 123(4):1008-25. PubMed ID: 26140483
[TBL] [Abstract][Full Text] [Related]
18. A parametric study delineating irreversible electroporation from thermal damage based on a minimally invasive intracranial procedure.
Garcia PA; Rossmeisl JH; Neal RE; Ellis TL; Davalos RV
Biomed Eng Online; 2011 Apr; 10():34. PubMed ID: 21529373
[TBL] [Abstract][Full Text] [Related]
19. A Study on Nonthermal Irreversible Electroporation of the Thyroid.
Lv Y; Zhang Y; Huang J; Wang Y; Rubinsky B
Technol Cancer Res Treat; 2019 Jan; 18():1533033819876307. PubMed ID: 31564220
[TBL] [Abstract][Full Text] [Related]
20. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
